You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

human parainfluenza vaccine

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3

Recruiting
  • Immunization
  • +2 more
  • 9-valent HPV vaccine, 2 dose efficacy
  • 9-valent HPV vaccine, 3 doses standard timing
  • Galveston, Texas
    University of Texas Medical Branch
Jan 30, 2023

Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant

Recruiting
  • Breast Carcinoma
  • +2 more
  • Recombinant human IL-7-hyFc (NT-I7)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)

Recruiting
  • Vaccine Response Impaired
  • BCG vaccine
  • +3 more
  • Adelaide, South Australia, Australia
    South Australian Health and Medical Research Institute
Nov 17, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Completed
  • Influenza
  • +4 more
  • Influenza vaccine [inactivated]
  • Kol'tsovo, Novosibirsk Region, Russian Federation
  • +4 more
May 11, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Recruiting
  • Influenza
  • +3 more
  • Influenza vaccine [inactivated]
  • Ekaterinburg, Russian Federation
  • +6 more
Feb 13, 2023

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

Completed
  • HIV Infections
  • +2 more
    • Baltimore, Maryland
    • +1 more
    Mar 17, 2023

    HPV, Human Papilloma Virus, Human Immunodeficiency Virus Trial in Vancouver (Nonavalent HPV vaccine)

    Not yet recruiting
    • HPV
    • +2 more
    • Nonavalent HPV vaccine
    • Vancouver, British Columbia, Canada
      University of British Columbia
    Aug 8, 2022

    Human Papilloma Virus Infection Trial (9-valent HPV vaccine)

    Not yet recruiting
    • Human Papilloma Virus Infection
    • 9-valent HPV vaccine
    • (no location specified)
    Jul 11, 2022

    Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

    Not yet recruiting
    • Healthy
    • H107e
    • +10 more
    • Pretoria, Gauteng, South Africa
      Aurum Institute
    Sep 24, 2023

    Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

    Active, not recruiting
    • Human Papillomavirus Infection
    • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
    • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
    • Guangzhou, Guangdong, China
    • +2 more
    Dec 30, 2022

    Influenza, Human Trial (Flu mRNA, Control 1, Control 2)

    Not yet recruiting
    • Influenza, Human
    • Flu mRNA
    • +2 more
    • (no location specified)
    Apr 21, 2023

    Prevention of Influenza Trial in Changsha (Investigational Vaccine(0.25ml/vial), Investigational Vaccine(0.5ml/vial), Active

    Not yet recruiting
    • Prevention of Influenza
    • Investigational Vaccine(0.25ml/vial)
    • +2 more
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Dec 6, 2022

    Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

    Not yet recruiting
    • Seasonal Influenza
    • Quadrivalent influenza vaccine(0.25ml)
    • +3 more
    • Lu'an, Anhui, China
    • +4 more
    Sep 15, 2023

    Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)

    Not yet recruiting
    • Influenza
    • Quadrivalent influenza virus subunit vaccine
    • Quadrivalent split influenza virus vaccine
    • Taizhou, Jiangsu, China
      Ab&b Biotechnology Co., Ltd.JS
    Jan 12, 2023

    Cholera, Cholera Vaccine Toxicity Trial in Boston (PanChol)

    Recruiting
    • Cholera
    • Cholera Vaccine Toxicity
    • PanChol
    • Boston, Massachusetts
      Brigham and Women's Hospital Vaccine Unit
    Dec 11, 2022

    HPV - Anogenital Human Papilloma Virus Infection, HIV Trial in Brussels (Vaccine)

    Active, not recruiting
    • HPV - Anogenital Human Papilloma Virus Infection
    • HIV Infections
    • Vaccine
    • Brussels, Belgium
      Service de Maladies Infectieuses, CHU Saint-Pierre
    Jul 19, 2022

    Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

    Recruiting
    • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +5 more
    • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection Trial in Hanzhou

    Active, not recruiting
    • Human Papilloma Virus Infection Type 16
    • +2 more
    • Cecolin
    • Hecolin
    • Hanzhou, Zhejiang, China
      Zhejiang Provincial Center for Disease Control and Prevention
    Jun 8, 2022

    Influenza Prevention Trial in Lenexa, Metairie, Cincinnati (INFLUENZA G1 mHA, Placebo, Al(OH)3)

    Recruiting
    • Influenza Prevention
    • INFLUENZA G1 mHA
    • +2 more
    • Lenexa, Kansas
    • +2 more
    Jun 5, 2023

    Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human

    Active, not recruiting
    • Human Papillomavirus Vaccine
    • 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
    • +2 more
    • Banjul, Outside U.S. And Canada, Gambia
      Ed Clarke
    Mar 15, 2022

    Cervical Intraepithelial Neoplasia Trial (HPV9 High formulation, HPV9 Medium formulation, HPV9 Low formulation)

    Not yet recruiting
    • Cervical Intraepithelial Neoplasia
    • HPV9 High formulation
    • +3 more
    • (no location specified)
    Aug 10, 2022

    Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi

    Active, not recruiting
    • Human Papilloma Virus Infection Type 16
    • +4 more
    • HPV+MMR（0d），HPV（6m）
    • +2 more
    • Shaoxing, Zhejiang, China
    • +1 more
    Mar 14, 2022

    Condylomata Acuminata Trial (low dosage HPV Vaccine, medium dosage HPV Vaccine, high dosage HPV Vaccine)

    Completed
    • Condylomata Acuminata
    • low dosage HPV Vaccine
    • +3 more
    • (no location specified)
    May 23, 2022

    Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))

    Completed
    • Influenza, Human
    • Treatment Group Live Attenuated Flu Vaccine (LAIV)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Dec 16, 2022